263 related articles for article (PubMed ID: 23406827)
1. Prospects for prophylactic hepatitis C vaccines based on virus-like particles.
Beaumont E; Roingeard P
Hum Vaccin Immunother; 2013 May; 9(5):1112-8. PubMed ID: 23406827
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus vaccines--progress and perspectives.
Fauvelle C; Lepiller Q; Felmlee DJ; Fofana I; Habersetzer F; Stoll-Keller F; Baumert TF; Fafi-Kremer S
Microb Pathog; 2013 May; 58():66-72. PubMed ID: 23499591
[TBL] [Abstract][Full Text] [Related]
3. Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.
Kumar A; Das S; Mullick R; Lahiri P; Tatineni R; Goswami D; Bhat P; Torresi J; Gowans EJ; Karande AA; Das S
Vaccine; 2016 Feb; 34(8):1115-25. PubMed ID: 26700891
[TBL] [Abstract][Full Text] [Related]
4. Virus-like particle-based vaccines against hepatitis C virus infection.
Bellier B; Klatzmann D
Expert Rev Vaccines; 2013 Feb; 12(2):143-54. PubMed ID: 23414406
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C vaccine. Need of the hour.
Verma R; Khanna P; Chawla S
Hum Vaccin Immunother; 2014; 10(7):1927-9. PubMed ID: 25424801
[TBL] [Abstract][Full Text] [Related]
6. Recent advancements in combination subunit vaccine development.
Tan M; Jiang X
Hum Vaccin Immunother; 2017 Jan; 13(1):180-185. PubMed ID: 27649319
[TBL] [Abstract][Full Text] [Related]
7. Progress in the development of vaccines for hepatitis C virus infection.
Ghasemi F; Rostami S; Meshkat Z
World J Gastroenterol; 2015 Nov; 21(42):11984-2002. PubMed ID: 26576087
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus vaccines among people who inject drugs.
Cox AL; Thomas DL
Clin Infect Dis; 2013 Aug; 57 Suppl 2(Suppl 2):S46-50. PubMed ID: 23884065
[TBL] [Abstract][Full Text] [Related]
9. Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design.
Roohvand F; Kossari N
Expert Opin Ther Pat; 2011 Dec; 21(12):1811-30. PubMed ID: 22022980
[TBL] [Abstract][Full Text] [Related]
10. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
[TBL] [Abstract][Full Text] [Related]
11. Vaccination for hepatitis C virus: closing in on an evasive target.
Halliday J; Klenerman P; Barnes E
Expert Rev Vaccines; 2011 May; 10(5):659-72. PubMed ID: 21604986
[TBL] [Abstract][Full Text] [Related]
12. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
13. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
[TBL] [Abstract][Full Text] [Related]
14. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.
Huret C; Desjardins D; Miyalou M; Levacher B; Amadoudji Zin M; Bonduelle O; Combadière B; Dalba C; Klatzmann D; Bellier B
Vaccine; 2013 Mar; 31(11):1540-7. PubMed ID: 22634300
[TBL] [Abstract][Full Text] [Related]
15. Methods to Evaluate Novel Hepatitis C Virus Vaccines.
Ahlén G; Frelin L
Methods Mol Biol; 2016; 1403():221-44. PubMed ID: 27076133
[TBL] [Abstract][Full Text] [Related]
16. Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists.
Christiansen D; Earnest-Silveira L; Chua B; Boo I; Drummer HE; Grubor-Bauk B; Gowans EJ; Jackson DC; Torresi J
Viral Immunol; 2018 May; 31(4):338-343. PubMed ID: 29489437
[TBL] [Abstract][Full Text] [Related]
17. A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.
Baumert TF; Fauvelle C; Chen DY; Lauer GM
J Hepatol; 2014 Nov; 61(1 Suppl):S34-44. PubMed ID: 25443345
[TBL] [Abstract][Full Text] [Related]
18. Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies.
Lauer GM
J Infect Dis; 2013 Mar; 207 Suppl 1():S7-S12. PubMed ID: 23390305
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery.
Christiansen D; Earnest-Silveira L; Grubor-Bauk B; Wijesundara DK; Boo I; Ramsland PA; Vincan E; Drummer HE; Gowans EJ; Torresi J
Sci Rep; 2019 Jun; 9(1):9251. PubMed ID: 31239471
[TBL] [Abstract][Full Text] [Related]
20. Approaches, Progress, and Challenges to Hepatitis C Vaccine Development.
Bailey JR; Barnes E; Cox AL
Gastroenterology; 2019 Jan; 156(2):418-430. PubMed ID: 30268785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
